Saffron Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 56.16%
- Profit Growth -31.02%
- Ebitda -27.10%
- Net Worth 11.79%
- Total Assets -12.60%
About Saffron Therapeutics
Saffron Therapeutics Private Limited (STPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2014 and has a history of Ten years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Singh and Hiren Patel serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233GJ2014PTC080089
- Company No.
080089
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
What products or services does Saffron Therapeutics Private Limited offer?
Saffron Therapeutics Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Pharmaceutical Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Health Conditions, Stomach Care.
Who are the key members and board of directors at Saffron Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Singh  | Director | 10-Jul-2014 | Current |
| Hiren Patel | Director | 25-Nov-2014 | Current |
Financial Performance of Saffron Therapeutics.
Saffron Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.16% increase. The company also saw a substantial fall in profitability, with a 31.02% decrease in profit. The company's net worth Soared by an impressive increase of 11.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saffron Therapeutics?
In 2023, Saffron Therapeutics had a promoter holding of 40.84% and a public holding of 59.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saffron Formulations Private LimitedAmit Singh and Hiren Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saffron Therapeutics?
Saffron Therapeutics has a workforce of 1 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saffron Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saffron Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Saffron Therapeutics
Recent activity within the organization
- Annual General Meeting
Saffron Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Saffron Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
- Director Appointment
Hiren Rameshchandra Patel was appointed as a Director was appointed as a Director on 25 Nov 2014 & has been associated with this company since 10 years 4 months .
- Director Appointment
Amit Singh was appointed as a Director was appointed as a Director on 10 Jul 2014 & has been associated with this company since 10 years 8 months .
- Company Incorporation
Saffron Therapeutics Private Limited was registered on 10 Jul 2014 with Roc Ahmedabad & aged 10 years 8 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Saffron Therapeutics Private Limited?
Saffron Therapeutics Private Limited was incorporated on 10 Jul 2014.
What is authorized share capital and paid-up capital of Saffron Therapeutics Private Limited?
The authorized share capital of Saffron Therapeutics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Saffron Therapeutics Private Limited?
Currently 2 directors are associated with Saffron Therapeutics Private Limited.
- Amit Singh
- Hiren Rameshchandra Patel
What is the registered address of Saffron Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Saffron Therapeutics Private Limited is B14 Sthapna Complex Near Ankur Bus Stand Opp. G.H.P. Naranpura, India, Ahmedabad, Gujarat, 380013.
What is the corporate identification number (CIN) and company number of Saffron Therapeutics Private Limited?
The corporate identification number (CIN) of Saffron Therapeutics Private Limited is U24233GJ2014PTC080089 and the company number is 080089 as per Ministry of Corporate Affairs (MCA).
What is the official website of Saffron Therapeutics Private Limited?
The Official website of Saffron Therapeutics Private Limited is https://www.saffrontherapeutics.com
What has been the recent revenue trend for Saffron Therapeutics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Saffron Therapeutics Private Limited has risen by 56.16%.
How many employees does Saffron Therapeutics Private Limited currently have?
As Per 2023 financial reports, 1 employees are currently employed by Saffron Therapeutics Private Limited.
What change has been observed in the net worth of Saffron Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Saffron Therapeutics Private Limited has experienced an upsurge of 11.79%.
When was the last Balance Sheet of Saffron Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Saffron Therapeutics Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
SP
Shalin ParikhDirectorAN
Anilkumar NegiDirectorRM
Ram MagarDirector